Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Receivables - Other (2018 - 2022)

NovaBridge Biosciences (NBP) has disclosed Receivables - Other for 5 consecutive years, with $1.2 million as the latest value for Q4 2022.

  • Quarterly Receivables - Other fell 76.58% to $1.2 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2022, down 76.58% year-over-year, with the annual reading at $4.9 million for FY2021, 85.92% down from the prior year.
  • Receivables - Other for Q4 2022 was $1.2 million at NovaBridge Biosciences, down from $4.9 million in the prior quarter.
  • The five-year high for Receivables - Other was $34.3 million in Q4 2020, with the low at $1.2 million in Q4 2022.
  • Average Receivables - Other over 5 years is $8.9 million, with a median of $2.3 million recorded in 2019.
  • The sharpest move saw Receivables - Other surged 1392.78% in 2020, then tumbled 85.6% in 2021.
  • Over 5 years, Receivables - Other stood at $1.6 million in 2018, then soared by 44.48% to $2.3 million in 2019, then soared by 1392.78% to $34.3 million in 2020, then crashed by 85.6% to $4.9 million in 2021, then crashed by 76.58% to $1.2 million in 2022.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $1.2 million, $4.9 million, and $34.3 million for Q4 2022, Q4 2021, and Q4 2020 respectively.